Maarten Postma

58PUBLICATIONS
129CO-AUTHORS
Urban community developmentNanotoxicology, health and safetyEpidemiological modellingImmunogenetics (incl. genetic immunology)Behavioural economics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (58)

|Aug 21, 2026
Cost-neutral adoption of anti-VEGF therapies in neovascular age-related macular degeneration.

|Jul 13, 2026
Unlocking herpes zoster vaccination value in Finland: return on investment and actuarial model.

|Mar 16, 2026
Cost per event avoided: adopt or avoid?

P Petrou, Olga Pitsillidou, Constantinos Petrou

|Mar 02, 2026
Cost Effectiveness of the Adjuvanted Recombinant Zoster Vaccine in Older Adults in Portugal.

Eleftherios Zarkadoulas, Fábio Silva, Joana Alves

Pageof 10